This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Stock indices represent aggregated price movements of selected groups of stocks, signaling market trends and sentiment for analysis.
16,340 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Microsoft stock remains volatile in mid-2026 as AI momentum collides with rising capex and a securities suit. Yet the...
When a tech CEO sells stock, investors pay attention. This article breaks down the implications of Adobe CEO Shantanu...
When a fund trims large holdings, it can signal shifting risk and opportunity. This article explains why an investmen...
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Ciena’s stock faced a sharp one-day retreat even after solid results, revealing how AI infrastructure optimism can cl...
Could Oracle become America’s next $1 trillion tech stock? This article weighs the growth catalysts, headwinds, and a...
Curious about SoundHound AI's future? This in-depth guide lays out five-year scenarios, key drivers, and concrete tip...
Big funds sometimes trim stakes in the market's most valuable names. This article breaks down why institutional inves...
Chipotle stock could see meaningful upside as management advances a multi-year expansion plan and digital push, even ...
As SpaceX eyes the public markets, investors buzz about a potential IPO rush and a comeback for stock-split enthusias...
In 2026, two very different gaming plays compete for attention: Roblox as a high-growth platform and GameStop as a tu...